Pathogenic variants of sphingomyelin synthase SMS2 disrupt lipid landscapes in the secretory pathway

  1. Tolulope Sokoya
  2. Jan Parolek
  3. Mads Møller Foged
  4. Dmytro I Danylchuk
  5. Manuel Bozan
  6. Bingshati Sarkar
  7. Angelika Hilderink
  8. Michael Philippi
  9. Lorenzo D Botto
  10. Paulien A Terhal
  11. Outi Mäkitie
  12. Jacob Piehler
  13. Yeongho Kim
  14. Christopher G Burd
  15. Andrey S Klymchenko
  16. Kenji Maeda
  17. Joost CM Holthuis  Is a corresponding author
  1. Osnabrück University, Germany
  2. Danish Cancer Society, Denmark
  3. Université de Strasbourg, UMR 7021, CNRS, France
  4. University of Utah, United States
  5. Utrecht University, Netherlands
  6. University of Helsinki, Finland
  7. Yale University, United States

Abstract

Sphingomyelin is a dominant sphingolipid in mammalian cells. Its production in the trans-Golgi traps cholesterol synthesized in the ER to promote formation of a sphingomyelin/sterol gradient along the secretory pathway. This gradient marks a fundamental transition in physical membrane properties that help specify organelle identify and function. We previously identified mutations in sphingomyelin synthase SMS2 that cause osteoporosis and skeletal dysplasia. Here we show that SMS2 variants linked to the most severe bone phenotypes retain full enzymatic activity but fail to leave the ER owing to a defective autonomous ER export signal. Cells harboring pathogenic SMS2 variants accumulate sphingomyelin in the ER and display a disrupted transbilayer sphingomyelin asymmetry. These aberrant sphingomyelin distributions also occur in patient-derived fibroblasts and are accompanied by imbalances in cholesterol organization, glycerophospholipid profiles and lipid order in the secretory pathway. We postulate that pathogenic SMS2 variants undermine the capacity of osteogenic cells to uphold nonrandom lipid distributions that are critical for their bone forming activity.

Data availability

All data generated or analysed during this study are included in the manuscript and supporting file. Source Data files have been provided for Figures 2-4, 7-9 and Appendix 1 - figure 3.

Article and author information

Author details

  1. Tolulope Sokoya

    Department of Biology and Center of Cellular Nanoanalytics, Osnabrück University, Osnabrück, Germany
    Competing interests
    The authors declare that no competing interests exist.
  2. Jan Parolek

    Department of Biology and Center of Cellular Nanoanalytics, Osnabrück University, Osnabrück, Germany
    Competing interests
    The authors declare that no competing interests exist.
  3. Mads Møller Foged

    Center for Autophagy, Recycling and Disease, Danish Cancer Society, Copenhagen, Denmark
    Competing interests
    The authors declare that no competing interests exist.
  4. Dmytro I Danylchuk

    Laboratoire de Bioimagerie et Pathologies, Université de Strasbourg, UMR 7021, CNRS, Strasbourg, France
    Competing interests
    The authors declare that no competing interests exist.
  5. Manuel Bozan

    Department of Biology and Center of Cellular Nanoanalytics, Osnabrück University, Osnabrück, Germany
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-8426-369X
  6. Bingshati Sarkar

    Department of Biology and Center of Cellular Nanoanalytics, Osnabrück University, Osnabrück, Germany
    Competing interests
    The authors declare that no competing interests exist.
  7. Angelika Hilderink

    Department of Biology and Center of Cellular Nanoanalytics, Osnabrück University, Osnabrück, Germany
    Competing interests
    The authors declare that no competing interests exist.
  8. Michael Philippi

    Department of Biology and Center of Cellular Nanoanalytics, Osnabrück University, Osnabrück, Germany
    Competing interests
    The authors declare that no competing interests exist.
  9. Lorenzo D Botto

    Department of Pediatrics, University of Utah, Salt Lake City, United States
    Competing interests
    The authors declare that no competing interests exist.
  10. Paulien A Terhal

    Department of Genetics, Utrecht University, Utrecht, Netherlands
    Competing interests
    The authors declare that no competing interests exist.
  11. Outi Mäkitie

    Children's Hospital, University of Helsinki, Helsinki, Finland
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-4547-001X
  12. Jacob Piehler

    Department of Biology and Center of Cellular Nanoanalytics, Osnabrück University, Osnabrück, Germany
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-2143-2270
  13. Yeongho Kim

    Department of Cell Biology, Yale University, New Haven, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-1477-925X
  14. Christopher G Burd

    Department of Cell Biology, Yale University, New Haven, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-1831-8706
  15. Andrey S Klymchenko

    Laboratoire de Bioimagerie et Pathologies, Université de Strasbourg, UMR 7021, CNRS, Strasbourg, France
    Competing interests
    The authors declare that no competing interests exist.
  16. Kenji Maeda

    Center for Autophagy, Recycling and Disease, Danish Cancer Society, Copenhagen, Denmark
    Competing interests
    The authors declare that no competing interests exist.
  17. Joost CM Holthuis

    Department of Biology and Center of Cellular Nanoanalytics, Osnabrück University, Osnabrück, Germany
    For correspondence
    jholthuis@uni-osnabrueck.de
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-8912-1586

Funding

Deutsche Forschungsgemeinschaft (SFB944-P14)

  • Joost CM Holthuis

Deutsche Forschungsgemeinschaft (HO3539/1-1)

  • Joost CM Holthuis

Deutsche Forschungsgemeinschaft (SFB944-P8)

  • Jacob Piehler

National Institutes of Health (R35 GM144096)

  • Christopher G Burd

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Copyright

© 2022, Sokoya et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 2,226
    views
  • 510
    downloads
  • 17
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Tolulope Sokoya
  2. Jan Parolek
  3. Mads Møller Foged
  4. Dmytro I Danylchuk
  5. Manuel Bozan
  6. Bingshati Sarkar
  7. Angelika Hilderink
  8. Michael Philippi
  9. Lorenzo D Botto
  10. Paulien A Terhal
  11. Outi Mäkitie
  12. Jacob Piehler
  13. Yeongho Kim
  14. Christopher G Burd
  15. Andrey S Klymchenko
  16. Kenji Maeda
  17. Joost CM Holthuis
(2022)
Pathogenic variants of sphingomyelin synthase SMS2 disrupt lipid landscapes in the secretory pathway
eLife 11:e79278.
https://doi.org/10.7554/eLife.79278

Share this article

https://doi.org/10.7554/eLife.79278

Further reading

    1. Biochemistry and Chemical Biology
    2. Cell Biology
    Kristina Ehring, Sophia Friederike Ehlers ... Kay Grobe
    Research Article

    The Sonic hedgehog (Shh) signaling pathway controls embryonic development and tissue homeostasis after birth. This requires regulated solubilization of dual-lipidated, firmly plasma membrane-associated Shh precursors from producing cells. Although it is firmly established that the resistance-nodulation-division transporter Dispatched (Disp) drives this process, it is less clear how lipidated Shh solubilization from the plasma membrane is achieved. We have previously shown that Disp promotes proteolytic solubilization of Shh from its lipidated terminal peptide anchors. This process, termed shedding, converts tightly membrane-associated hydrophobic Shh precursors into delipidated soluble proteins. We show here that Disp-mediated Shh shedding is modulated by a serum factor that we identify as high-density lipoprotein (HDL). In addition to serving as a soluble sink for free membrane cholesterol, HDLs also accept the cholesterol-modified Shh peptide from Disp. The cholesteroylated Shh peptide is necessary and sufficient for Disp-mediated transfer because artificially cholesteroylated mCherry associates with HDL in a Disp-dependent manner, whereas an N-palmitoylated Shh variant lacking C-cholesterol does not. Disp-mediated Shh transfer to HDL is completed by proteolytic processing of the palmitoylated N-terminal membrane anchor. In contrast to dual-processed soluble Shh with moderate bioactivity, HDL-associated N-processed Shh is highly bioactive. We propose that the purpose of generating different soluble forms of Shh from the dual-lipidated precursor is to tune cellular responses in a tissue-type and time-specific manner.

    1. Biochemistry and Chemical Biology
    2. Cell Biology
    Gina Partipilo, Yang Gao ... Benjamin K Keitz
    Feature Article

    Troubleshooting is an important part of experimental research, but graduate students rarely receive formal training in this skill. In this article, we describe an initiative called Pipettes and Problem Solving that we developed to teach troubleshooting skills to graduate students at the University of Texas at Austin. An experienced researcher presents details of a hypothetical experiment that has produced unexpected results, and students have to propose new experiments that will help identify the source of the problem. We also provide slides and other resources that can be used to facilitate problem solving and teach troubleshooting skills at other institutions.